<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR122">
 <label>122.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tsybalova</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Stepanova</surname>
    <given-names>LA</given-names>
   </name>
   <name>
    <surname>Kuprianov</surname>
    <given-names>VV</given-names>
   </name>
   <name>
    <surname>Blokhina</surname>
    <given-names>EA</given-names>
   </name>
   <name>
    <surname>Potapchuk</surname>
    <given-names>MV</given-names>
   </name>
   <name>
    <surname>Korotkov</surname>
    <given-names>AV</given-names>
   </name>
   <name>
    <surname>Gorshkov</surname>
    <given-names>AN</given-names>
   </name>
   <name>
    <surname>Kasyanenko</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Ravin</surname>
    <given-names>NV</given-names>
   </name>
   <name>
    <surname>Kiselev</surname>
    <given-names>OI</given-names>
   </name>
  </person-group>
  <article-title>Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: broad protective efficacy of particles carrying four copies of M2e</article-title>
  <source>Vaccine</source>
  <year>2015</year>
  <volume>33</volume>
  <issue>29</issue>
  <fpage>3398</fpage>
  <lpage>3406</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.04.073</pub-id>
  <?supplied-pmid 25976545?>
  <pub-id pub-id-type="pmid">25976545</pub-id>
 </element-citation>
</ref>
